ADCP FcγRIIa(131H) Jurkat GFP Effector Cell LineADCP Reporter细胞系选择了ADCP作用机制通路激活过程中较早的事件作为检测的读出指标:即效应细胞中由 NFAT通路介导的基因转录的激活。此外,ADCP报告基因检测试剂盒使用工程改造的 Jurkat 细胞作为效应细胞,该细胞稳定表达了FcγRIIa受体(高亲和131H)和由NFAT应答元件...
吉满生物科技(Genomeditech)依靠多年研究经验,利用巧妙的载体设计和第三代慢病毒报告基因系统,推出了ADCC/ADCP相关细胞系和ADCC/ADCP活性检测服务,并可接受ADCC/ADCP细胞系定制服务。 ADCC FcγRIIIa(158F) Jurkat Effector Cell Line ADCC FcγRIIIa(158V) Jurkat Effector Cell Line ADCC Reporter细胞系选择了ADCC...
单克隆+#5+H_FCGR3A(CD16a) 158F CHO-K1 Cell Line+PE anti-human CD16 Antibody+biolegend+流式结果 吉满生物助力药物研发,紧随前沿靶点资讯,储备几百株现货细胞,覆盖GPCR、细胞因子、免疫检查点、TAA等多领域近300余个靶点。 部分细胞/抗体产品列表 来源:DDXCELL官方 ...
吉满生物 ADCC FcγRIIIa(158V) DDX35TM Jurkat Effector Cell Line 报告基因细胞系采用工程改造的 Jurkat 细胞作为效应细胞。利用巧妙的载体设计和第三代慢病毒报告基因系统,稳定表达了人 FcγRIIIa 受体(158V)和由转录因子驱动表达的萤火虫萤光素酶,抗体在 ADCC 作用机制中的生物活性通过 NFAT 通路活化产生的...
ADCP FcγRIIa(131H) Jurkat GFP Effector Cell Line ADCP Reporter细胞系选择了ADCP作用机制通路激活过程中较早的事件作为检测的读出指标:即效应细胞中由 NFAT通路介导的基因转录的激活。此外,ADCP报告基因检测试剂盒使用工程改造的 Jurkat 细胞作为效应细胞,该细胞稳定表达了FcγRIIa受体(高亲和131H)和由NFAT应答元...
ADCC FcγRIIIa(158V) Jurkat Effector Cell Line ADCC Reporter细胞系选择了ADCC作用机制通路激活过程中较早的事件作为检测的读出指标:即效应细胞中由 NFAT通路介导的基因转录的激活。此外ADCC报告基因检测试剂盒使用工程改造的 Jurkat 细胞作为效应细胞,该细胞稳定表达了FcγRIIIa受体(158F/158V)和由NFAT应答元件...
TARGET CELL PORTFOLIO Engineered, homologous, and specific target cells that enable screening for Antibody induced effectorfunctions Learn more Can´t find a perfect match?Let us develop it for you! In case you haven't got an ideal target cell line and can't find what you’re looking for ...
CHOFlow unifies the proven FUT8 genetic knock-out glycosylation strategy with excellent productivities (> 5 g/L) and a robust and stable production process of our CHONAMITE® host cell line.——内容来自FyoniBio GmbH 汉腾生物欧洲子公司FyoniBio GmbH已构建全新的专有糖基化修饰的 CHOFlow细胞系...
Figure 1: Demonstration that an afucosylated antibody produced from the WuXiaADCCPLUSTM cell line exhibits significantly enhanced ADCC activity Removal of fucose on the N-glycosylation site is an efficient and cost-effective way to enhance ADCC activity and increase the potency of antibody-based immuno...
Jurkat-Lucia™ NFAT-CD16 cells and Jurkat-Lucia™ NFAT-CD16-Low cells were engineered from the human T lymphocyte Jurkat cell line to assess the potency of specific antibodies/immunoglobulin for antibody-dependent cellular cytotoxicity (ADCC): — Jurkat-Lucia™ NFAT-CD16 cells featuring the...